Oscar Health (NYSE:OSCR) CEO Sells 614,752 Shares

Oscar Health, Inc. (NYSE:OSCR) CEO Mark Bertolini sold 614,752 shares of the stock in a transaction on Monday, June 29th. The shares were sold at an average price of $29.26, for a total value of $17,987,643.52. Following the completion of the transaction, the chief executive officer owned 8,375,814 shares in the company, valued at $245,076,317.64. The trade was a 6.84% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Trading Up 11.4%

Shares of OSCR stock traded up $3.27 on Wednesday, reaching $31.79. 7,076,110 shares of the stock were exchanged, compared to its average volume of 7,810,169. The stock has a market cap of $9.58 billion, a PE ratio of -53.87, a P/E/G ratio of 2.06 and a beta of 2.37. Oscar Health, Inc. has a one year low of $10.69 and a one year high of $32.06. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11. The stock has a 50 day moving average price of $23.56 and a 200 day moving average price of $17.55.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.96. The business had revenue of $4.65 billion for the quarter, compared to analysts’ expectations of $4.90 billion. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The firm’s quarterly revenue was up 52.6% compared to the same quarter last year. During the same quarter last year, the business earned $0.92 earnings per share. Equities research analysts forecast that Oscar Health, Inc. will post 0.47 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

OSCR has been the subject of several analyst reports. Wells Fargo & Company set a $20.00 price target on shares of Oscar Health and gave the stock an “equal weight” rating in a research report on Thursday, June 4th. Robert W. Baird raised their price objective on shares of Oscar Health from $15.00 to $19.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Wolfe Research assumed coverage on shares of Oscar Health in a report on Tuesday, May 5th. They set a “peer perform” rating for the company. Wall Street Zen upgraded shares of Oscar Health from a “buy” rating to a “strong-buy” rating in a research report on Sunday, June 14th. Finally, Weiss Ratings downgraded Oscar Health from a “sell (d+)” rating to a “sell (d)” rating in a research note on Wednesday, June 24th. Three research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $20.78.

Institutional Trading of Oscar Health

A number of institutional investors and hedge funds have recently modified their holdings of OSCR. Vanguard Group Inc. raised its holdings in shares of Oscar Health by 2.7% during the fourth quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock worth $297,477,000 after acquiring an additional 540,851 shares during the period. T. Rowe Price Investment Management Inc. boosted its stake in Oscar Health by 11.0% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 9,217,816 shares of the company’s stock worth $132,461,000 after purchasing an additional 910,320 shares during the period. Morgan Stanley increased its holdings in Oscar Health by 42.8% during the 4th quarter. Morgan Stanley now owns 6,814,046 shares of the company’s stock worth $97,918,000 after purchasing an additional 2,043,758 shares in the last quarter. Thrive Capital Management LLC raised its stake in shares of Oscar Health by 33.4% in the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after purchasing an additional 1,588,395 shares during the period. Finally, BIT Capital GmbH raised its stake in shares of Oscar Health by 545.0% in the 4th quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock valued at $88,897,000 after purchasing an additional 5,227,152 shares during the period. 75.70% of the stock is owned by institutional investors.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.